| 期 |
标题 |
文件 |
| 卷 31, 编号 9 (2024) |
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) |
(Eng)
|
|
De S.
|
| 卷 31, 编号 23 (2024) |
Drug Delivery Systems based on Microneedles for Dermatological Diseases and Aesthetic Enhancement |
(Eng)
|
|
Vergilio M., Birchall J., Lima L., Rezende R., Leonardi G.
|
| 卷 31, 编号 23 (2024) |
Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review |
(Eng)
|
|
Dana P., Hallajzadeh J., Asemi Z., Mansournia M., Yousefi B.
|
| 卷 31, 编号 23 (2024) |
Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases |
(Eng)
|
|
Kumari P., Beeraka N., Tengli A., Bannimath G., Baath R., Patil M.
|
| 卷 31, 编号 23 (2024) |
Involvement of Nrf2 Signaling in Lead-induced Toxicity |
(Eng)
|
|
Arabnezhad M., Haghani F., Ghaffarian-Bahraman A., Jafarzadeh E., Mohammadi H., Yadegari J., Farkhondeh T., Aschner M., Darroudi M., Marouzi S., Samarghandian S.
|
| 卷 31, 编号 23 (2024) |
An Updated Review on the Significance of DNA and Protein Methyltransferases and De-methylases in Human Diseases: From Molecular Mechanism to Novel Therapeutic Approaches |
(Eng)
|
|
Ghanbari M., Khosroshahi N., Alamdar M., Abdi A., Aghazadeh A., Feizi M., Haghi M.
|
| 卷 31, 编号 23 (2024) |
The Chemoprotective Potentials of Alpha-lipoic Acid against Cisplatin-induced Ototoxicity: A Systematic Review |
(Eng)
|
|
Zabibah R., Gupta J., Iqbal M., Iswanto A., Farhood B., Lateef Al-Awsi G., Arshed U., Arif A., Ramírez-Coronel A., Alhassan M., Mustafa Y., Rahman F.
|
| 卷 31, 编号 23 (2024) |
Essential Trace Elements in Patients with Dyslipidemia: A Meta-analysis |
(Eng)
|
|
Li C., Song Y., Lin Z., Ma M., He L.
|
| 卷 31, 编号 23 (2024) |
Effects of Dietary Flavonoids on the Metabolism of Vortioxetine and its Potential Mechanism |
(Eng)
|
|
Lin Y., Wang Y., Ye Z., Gao N., Xu X., Weng Q., Xu R., Ye L.
|
| 卷 31, 编号 23 (2024) |
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis |
(Eng)
|
|
Mahmoudi A., Butler A., De Vincentis A., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 28 (2024) |
Georgian Medicinal Plants as Rich Natural Sources of Antioxidant Derivatives: A Review on the Current Knowledge and Future Perspectives |
(Eng)
|
|
Pirtskhalava M., Mittova V., Tsetskhladze Z., Palumbo R., Pastore R., Roviello G.
|
| 卷 31, 编号 23 (2024) |
Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders? |
(Eng)
|
|
Dell'Osso L., Nardi B., Massoni L., Gravina D., Benedetti F., Cremone I., Carpita B.
|
| 卷 31, 编号 20 (2024) |
Effects of Trehalose Administration in Patients with Mucopolysaccharidosis Type III |
(Eng)
|
|
Mobini M., Radbakhsh S., Kubaski F., Eshraghi P., Vakili S., Vakili R., Abbasifard M., Jamialahmadi T., Rajabi O., Emami S., Tayarani-Najaran Z., Rizzo M., Eid A., Banach M., Sahebkar A.
|
| 卷 31, 编号 20 (2024) |
Thiazole, Isatin and Phthalimide Derivatives Tested in vivo against Cancer Models: A Literature Review of the Last Six Years |
(Eng)
|
|
Pinto A., Nunes J., Severino Martins J., Leal A., Silva C., da Silva A., da Cruz Olímpio D., da Silva E., Campos T., Lima Leite A.
|
| 卷 31, 编号 20 (2024) |
The Applications of Molecular Dynamics Simulation in Studying Protein Structure and Dynamics |
(Eng)
|
|
Guo J., Liu H.
|
| 卷 31, 编号 20 (2024) |
Computational Protein Design - Where it goes? |
(Eng)
|
|
Xu B., Chen Y., Xue W.
|
| 卷 31, 编号 20 (2024) |
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation |
(Eng)
|
|
Zhong H., Liu H., Liu H.
|
| 卷 31, 编号 20 (2024) |
Screening and Activity Evaluation of Novel BCR-ABL/T315I Tyrosine Kinase Inhibitors |
(Eng)
|
|
Su J., Fu C., Wang S., Chen X., Wang R., Shi H., Li J., Wang X.
|
| 卷 31, 编号 20 (2024) |
Neurosteroids and their Therapeutic Potential: Remembering the Contribution of Dr. Sabina Luchetti, Netherlands Institute for Neuroscience, Amsterdam, Netherlands |
(Eng)
|
|
di Michele F.
|
| 卷 31, 编号 20 (2024) |
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors |
(Eng)
|
|
Du S., Fang Y., Zhang W., Rao G.
|
| 卷 31, 编号 20 (2024) |
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists |
(Eng)
|
|
Fang H., Niu B., Chen Q.
|
| 卷 31, 编号 20 (2024) |
An Investigation into the Effects of Chemical, Pharmaceutical, and Herbal Compounds on Neuroglobin: A Literature Review |
(Eng)
|
|
Hamedani S., Pourmasoumi M., Askari G., Bagherniya M., Sathyapalan T., Sahebkar A.
|
| 卷 31, 编号 20 (2024) |
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications |
(Eng)
|
|
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
|
| 卷 31, 编号 20 (2024) |
The Function of Autophagy in the Initiation, and Development of Breast Cancer |
(Eng)
|
|
Beilankouhi E., Valilo M., Dastmalchi N., Teimourian S., Safaralizadeh R.
|
| 卷 31, 编号 28 (2024) |
Treatment of MRSA Infection: Where are We? |
(Eng)
|
|
Nazli A., Tao W., You H., He X., He Y.
|
| 卷 31, 编号 28 (2024) |
Biomarkers for Diagnosing and Treating Fetal Growth Restriction |
(Eng)
|
|
Wu M., He J., Chen Y., Wan F., Tang H., Yin C., He H., Yu H., Yuan C.
|
| 卷 31, 编号 31 (2024) |
Blood-based microRNAs as Potential Diagnostic Biomarkers for Melanoma: A Meta-Analysis |
(Eng)
|
|
Aalami A., Abdeahad H., Mokhtari A., Aalami F., Amirabadi A., Aliabadi E., Pirzade O., Sahebkar A.
|
| 卷 31, 编号 31 (2024) |
Prediction of Human Microbe-Drug Association based on Layer Attention Graph Convolutional Network |
(Eng)
|
|
Qu J., Ni J., Ni T., Bian Z., Liang J.
|
| 卷 31, 编号 36 (2024) |
The Impact of Alcohol-Induced Epigenetic Modifications in the Treatment of Alcohol use Disorders |
(Eng)
|
|
Fanfarillo F., Ferraguti G., Lucarelli M., Fuso A., Ceccanti M., Terracina S., Micangeli G., Tarani L., Fiore M.
|
| 卷 31, 编号 36 (2024) |
An Updated Review For Hyperuricemia and Gout Management; Special Focus on the Available Drug Delivery Systems and Clinical Trials |
(Eng)
|
|
Karantas I., Miliotou A., Siafaka P.
|
| 卷 31, 编号 36 (2024) |
Bacterial Polyhydroxyalkanoates-based Therapeutics-delivery Nano-systems |
(Eng)
|
|
Durán-Lara E., Rafael D., Andrade F., G. O., Vijayakumar S.
|
| 卷 31, 编号 36 (2024) |
Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives |
(Eng)
|
|
Tajbakhsh A., Yousefi F., Farahani N., Savardashtaki A., Reiner ., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 36 (2024) |
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review |
(Eng)
|
|
Metwally K., Abo-Dya N.
|
| 卷 31, 编号 36 (2024) |
The Effects of Curcumin on Brain-Derived Neurotrophic Factor Expression in Neurodegenerative Disorders |
(Eng)
|
|
Radbakhsh S., Butler A., Moallem S., Sahebkar A.
|
| 卷 31, 编号 36 (2024) |
Graph Neural Networks with Multi-features for Predicting Cocrystals using APIs and Coformers Interactions |
(Eng)
|
|
Mswahili M., Jo K., Lee S., Jeong Y.
|
| 卷 31, 编号 36 (2024) |
Unlocking the Immunomodulatory Potential of Rosmarinic Acid Isolated from Punica granatum L. using Bioactivity-Guided Approach: In Silico, In Vitro, and In Vivo Approaches |
(Eng)
|
|
Gautam R., Tripathi S., Akash S., Sharma S., Sharma K., Goyal S., Behzad S., Gundamaraju R., Mishra D., Zhang Y., Shen B., Sundriyal S., Singla R.
|
| 卷 31, 编号 31 (2024) |
Natural Products in Liver Fibrosis Management: A Five-year Review |
(Eng)
|
|
Wang T., Lu Z., Sun G., He K., Chen Z., Qu X., Han X.
|
| 卷 31, 编号 31 (2024) |
Linoleic and Arachidonic Fatty Acids and their Potential Relationship with Inflammation, Pregnancy, and Fetal Development |
(Eng)
|
|
Ortiz M., Álvarez D., Muñoz Y., Crisosto N., Valenzuela R., Maliqueo M.
|
| 卷 31, 编号 31 (2024) |
Natural Plant Materials as a Source of Neuroprotective Peptides |
(Eng)
|
|
Skibska A., Perlikowska R.
|
| 卷 31, 编号 28 (2024) |
Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy |
(Eng)
|
|
Gautam R., Mittal P., Goyal R., Dua K., Mishra D., Sharma S., Singla R.
|
| 卷 31, 编号 28 (2024) |
An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting Strategies |
(Eng)
|
|
Mortezaee K., Majidpoor J.
|
| 卷 31, 编号 28 (2024) |
Kidney Injury: Focus on Molecular Signaling Pathways |
(Eng)
|
|
Liu W., Hu M., Wang L., Mirzaei H.
|
| 卷 31, 编号 28 (2024) |
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase |
(Eng)
|
|
Bui K., Nguyen T., Barat S., Scholta T., Xing J., Bhuria V., Sipos B., Wilkens L., Nguyen L., Le H., Velavan T., Bozko P., Plentz R.
|
| 卷 31, 编号 28 (2024) |
Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation |
(Eng)
|
|
Yuan Y., Li Q., Chen F., Zhao Y., Ma J., Fang S.
|
| 卷 31, 编号 28 (2024) |
The Combined Effect of Curcumin and Crocin on the Reduction of Inflammatory Responses in Arthritic Rats |
(Eng)
|
|
Rashidi K., Korani M., Nemati H., Shahraki R., Korani S., Abbasifard M., Majeed M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 31 (2024) |
Ferroptosis-induced Cardiotoxicity and Antitumor Drugs |
(Eng)
|
|
Beretta G.
|
| 卷 31, 编号 31 (2024) |
Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment? |
(Eng)
|
|
Hao S., Cai D., Gou S., Li Y., Liu L., Tang X., Chen Y., Zhao Y., Shen J., Wu X., Li M., Chen M., Li X., Sun Y., Gu L., Li W., Wang F., Cho C., Xiao Z., Du F.
|
| 卷 31, 编号 31 (2024) |
Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening |
(Eng)
|
|
Zhu Y., Yang S., Zhang T., Ge Y., Wan X., Liang G.
|
| 卷 31, 编号 31 (2024) |
Aducanumab in Alzheimers Disease: A Critical Update |
(Eng)
|
|
Ashique S., Sirohi E., Kumar S., Rihan M., Mishra N., Bhatt S., Gautam R., Singh S., Gupta G., Chellappan D., Dua K.
|
| 卷 31, 编号 36 (2024) |
Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation |
(Eng)
|
|
Lin C., Wu L., Tsai F.
|
| 卷 31, 编号 42 (2024) |
Current Targets and Future Directions of Positive Inotropes for Heart Failure |
(Eng)
|
|
Fairuz S., Ang C., Mraiche F., Goh J.
|
| 卷 31, 编号 5 (2024) |
Pharmacophore & QSAR Guided Design, Synthesis, Pharmacokinetics and In vitro Evaluation of Curcumin Analogs for Anticancer Activity |
(Eng)
|
|
Alam S., Verma S., Fatima K., Luqman S., Srivastava S., Khan F.
|
| 卷 31, 编号 5 (2024) |
Generation of Autoantibodies in Metal-catalyzed Oxidatively Damaged DNA in Various Cancer Subjects |
(Eng)
|
|
Ahmad S., Alshammari Q., Rafi Z., Rehman S., Khan M., Faisal M., Alatar A.
|
| 卷 31, 编号 5 (2024) |
Integrated High-throughput Transcriptomic Data Identifies Survivin as a Potential Breast Cancer Therapeutic Biomarker |
(Eng)
|
|
Mirza Z.
|
| 卷 31, 编号 6 (2024) |
Meet the Regional Editor |
(Eng)
|
|
Chen C.
|
| 卷 31, 编号 6 (2024) |
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 6 (2024) |
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective |
(Eng)
|
|
Drenichev M., Borokh V.
|
| 卷 31, 编号 6 (2024) |
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency |
(Eng)
|
|
De S.
|
| 卷 31, 编号 6 (2024) |
LncRNA PVT1 as a Novel Biomarker for Diabetes-related Complications |
(Eng)
|
|
Qiu X., Chen J., Yang J., Hu J., Fan P., Yuan C.
|
| 卷 31, 编号 6 (2024) |
Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications |
(Eng)
|
|
Chen Y., Kanwar Y., Chen X., Zhan M.
|
| 卷 31, 编号 6 (2024) |
Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy |
(Eng)
|
|
Quijia C., Enríquez A., Zappia C., Peroni R., Chorilli M.
|
| 卷 31, 编号 5 (2024) |
Structure-based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Metabolic Reactivity Studies of Quinazoline Derivatives for their Anti-EGFR Activity Against Tumor Angiogenesis |
(Eng)
|
|
Shah A., Ahmad S., Yadav M., Raza K., Kamal M., Akhtar S.
|
| 卷 31, 编号 5 (2024) |
The Efficient Activity of Glabridin and its Derivatives Against EGFRmediated Inhibition of Breast Cancer |
(Eng)
|
|
Ghosh A., Ghosh D., Mukerjee N., Maitra S., Das P., Dey A., Sharkawi S., Zouganelis G., Alexiou A., Chaudhari S., Sharma R., Waghmare S., Papadakis M., Batiha G.
|
| 卷 31, 编号 5 (2024) |
Novel Computational Methods for Cancer Drug Design |
(Eng)
|
|
Talluri S., Kamal M., Malla R.
|
| 卷 31, 编号 42 (2024) |
The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review |
(Eng)
|
|
Gupta J., Jalil A., Riyad Muedii Z., Aminov Z., Alsaikhan F., Ramírez-Coronel A., Ramaiah P., Farhood B.
|
| 卷 31, 编号 42 (2024) |
Single-cell RNA Sequencing Analysis Reveals the Role of Cancerassociated Fibroblasts in Skin Melanoma |
(Eng)
|
|
Lian W., Xiang P., Ye C., Xiong J.
|
| 卷 31, 编号 42 (2024) |
Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma |
(Eng)
|
|
Du Y., Jiang X., Zhang Y., Ying J., Yi Q.
|
| 卷 31, 编号 42 (2024) |
Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer |
(Eng)
|
|
Tian Y., Xie Y., Yi G., Wu F., Dang X., Bai F., Wang J., Zhang D.
|
| 卷 31, 编号 42 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| 卷 31, 编号 42 (2024) |
Identifying Hub Genes for Glaucoma based on Bulk RNA Sequencing Data and Multi-machine Learning Models |
(Eng)
|
|
Xie Y., Yu K.
|
| 卷 31, 编号 42 (2024) |
Perillyl Alcohol Promotes Relaxation in Human Umbilical Artery |
(Eng)
|
|
de Sena Bastos C., Pereira-de-Morais L., de Alencar Silva A., de Menezes Dantas D., Batista P., Gomes M., de Araújo Delmondes G., de Menezes I., da Silva R., Barbosa R.
|
| 卷 31, 编号 5 (2024) |
Imidazo[4,5-b]Pyridines: From Kinase Inhibitors to more Diversified Biological Properties |
(Eng)
|
|
Jarmoni K., Misbahi K., Ferrières V.
|
| 卷 31, 编号 5 (2024) |
Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones |
(Eng)
|
|
Neganova M., Liu J., Aleksandrova Y., Vasilieva N., Semakov A., Yandulova E., Sukocheva O., Balakin K., Klochkov S., Fan R.
|
| 卷 31, 编号 5 (2024) |
Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs |
(Eng)
|
|
Kamal M., Akhtar S.
|
| 卷 31, 编号 6 (2024) |
Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis |
(Eng)
|
|
Zhang X., Lou D., Fu R., Wu F., Zheng D., Ma X.
|
| 卷 31, 编号 6 (2024) |
Circulating Levels of 5-HT and BDNF in Adults with Autism Spectrum Conditions: An Investigation in a Sample of Subjects with Autism Spectrum Disorder, their First-degree Relatives and Controls |
(Eng)
|
|
Carpita B., Stagnari R., Palego L., Baroni D., Massimetti G., Nardi B., Cremone I., Betti L., Giannaccini G., Dell'Osso L.
|
| 卷 31, 编号 8 (2024) |
Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases |
(Eng)
|
|
Chen Y., Li X.
|
| 卷 31, 编号 8 (2024) |
Research Progress in Small Molecules as Anti-vitiligo Agents |
(Eng)
|
|
Wu H., Niu C., Aisa H.
|
| 卷 31, 编号 8 (2024) |
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases |
(Eng)
|
|
De S.
|
| 卷 31, 编号 8 (2024) |
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 9 (2024) |
Meet the Regional Editor |
(Eng)
|
|
Campos J.
|
| 卷 31, 编号 9 (2024) |
Metabolic Reprogramming of Immune Cells Following Vaccination: From Metabolites to Personalized Vaccinology |
(Eng)
|
|
Mussap M., Puddu M., Fanos V.
|
| 卷 31, 编号 9 (2024) |
NLS-3 (Levophacetoperane or (R,R) Phacetoperane): A Reverse Ester of Methylphenidate: A Literature Review |
(Eng)
|
|
Konofal E., Lecendreux M., Bizot J., Lormier A., Figadère B.
|
| 卷 31, 编号 9 (2024) |
Research Progress in the Clinical Treatment of Familial Hypercholesterolemia |
(Eng)
|
|
Ai J., Zhao P., Zhang W., Rao G.
|
| 卷 31, 编号 9 (2024) |
Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells |
(Eng)
|
|
Homayoonfal M., Aminianfar A., Asemi Z., Yousefi B.
|
| 卷 31, 编号 9 (2024) |
The Impact of lncRNA-GAS5/miRNA-200/ACE2 Molecular Pathway on the Severity of COVID-19 |
(Eng)
|
|
Ayeldeen G., Shaker O., Amer E., Zaafan M., Herzalla M., Keshk M., Abdelhamid A.
|
| 卷 31, 编号 8 (2024) |
Enlightening the Mechanism of Ferroptosis in Epileptic Heart |
(Eng)
|
|
Akyüz E., Saleem Q., Sari Ç., Auzmendi J., Lazarowski A.
|
| 卷 31, 编号 8 (2024) |
Perspective and Prospects on Persistent Luminescent Nanoparticles for Biological Imaging and Tumor Therapy |
(Eng)
|
|
Sun M., Chen M., Wang J.
|
| 卷 31, 编号 8 (2024) |
A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases |
(Eng)
|
|
Olatunde O., Yong J., Lu C., Ming Y.
|
| 卷 31, 编号 7 (2024) |
Prof. Dr. Ferid Murad (Nobel Laureate), a Great Friend of Bentham Science, Dies at the Age of 86 |
(Eng)
|
|
|
| 卷 31, 编号 7 (2024) |
First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 7 (2024) |
Challenges of Natural Anticancer and Anti-inflammatory Agents |
(Eng)
|
|
Scotti M., Scotti L.
|
| 卷 31, 编号 7 (2024) |
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review |
(Eng)
|
|
Sehrawat R., Rathee P., Khatkar S., Akkol E., Khayatkashani M., Nabavi S., Khatkar A.
|
| 卷 31, 编号 7 (2024) |
In silico Studies on Natural Products and Derivatives against Different Types of Cancer |
(Eng)
|
|
Messias Monteiro A., da Silva F., Rodrigues T., Ramos C., Scotti M., Scotti L.
|
| 卷 31, 编号 7 (2024) |
Natural Anticancer Agents: Their Therapeutic Potential, Challenges and Promising Outcomes |
(Eng)
|
|
Tauro S., Dhokchawle B., Mohite P., Nahar D., Nadar S., Coutinho E.
|
| 卷 31, 编号 7 (2024) |
Natural Coumarin Derivatives Targeting Melanoma |
(Eng)
|
|
Silva L., Nunes J., Zhan P., Łączkowski K., Cardoso S., da Silva-Júnior E.
|
| 卷 31, 编号 7 (2024) |
Zingiber officinale Roscoe (Ginger) and its Bioactive Compounds in Diabetes: A Systematic Review of Clinical Studies and Insight of Mechanism of Action |
(Eng)
|
|
Van B., Abdalla A., Algarni A., Khalid A., Zengin G., Aumeeruddy M., Mahomoodally M.
|
| 卷 31, 编号 7 (2024) |
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases |
(Eng)
|
|
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
|
| 卷 31, 编号 8 (2024) |
Meet the Country Editor |
(Eng)
|
|
Marazziti D.
|
| 卷 31, 编号 9 (2024) |
PAFAH1B3 Regulates Papillary Thyroid Carcinoma Cell Proliferation and Metastasis by Affecting the EMT |
(Eng)
|
|
Jiang W., Quan R., Bhandari A., Hirachan S., Chen C., Lv S., Zheng C.
|
| 101 - 200 的 400 信息 |
<< < 1 2 3 4 > >>
|
